Coping strategies in advanced lung cancer patients referred for specialist palliative care – validation of Brief COPE inventory in Hindi

Completed

• Conditions: Malignant neoplasm of bronchus andlung,

• Registration Number: CTRI/2019/06/019902
• Lead Sponsor: Tata Memorial Hospital

Brief Summary

Lung cancer is the most common cancer worldwide in males and females combined, accounting for 11.6% of the total cancer patients and  the leading cause of cancer death  accounting for 18.4% of the total cancer deaths. It is the expected to be the 6th most common cause of death by 2030. In India, according to GLOBOCAN 2018, approximately 70,000 new cases of lung cancer were estimated in male and female combined with a very high mortality rate.

At every stage of the disease, patients with lung cancer can find themselves dealing with distressing and difficult situations. They can develop various problems like sadness, depression and other psychological symptoms which can even interfere with their daily functioning.

Patients with incurable lung and gastrointestinal cancer who received Early Palliative Care (EPC) showed increased use of approach-oriented coping, associated with better Quality of Life and decreased negative symptoms like depression.

Most of the studies done in the area of coping strategies in advanced lung cancer are from developed countries where the sociodemographic scenarios are different from developing countries. The studies done in India on coping strategies have included advanced cancer patients in general. No studies have addressed coping strategies in advanced lung cancer patients specifically and in specialist palliative care setting, to the best of our knowledge.Also Brief COPE has not been validated in Hindi version for use in this group of patients.

The aim for this study is to validate the Brief COPE in Hindi language to assess the coping strategies of advanced lung cancer patients referred for specialist palliative care, in the context of a tertiary care cancer centre in a developing country.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-07
• Study Completion: 2021-09-02
• Last Update Posted: 2021-10-05

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 340

Inclusion Criteria

1.Patients with advanced lung cancer 2.Newly referred to Department of Palliative Medicine (outpatients and inpatients) or attending follow up (clinic based or home based) 3.Age above 18 years and willing to participate 4.Able to read and understand the appropriate language (English/Hindi) 5.Able to give written informed consent for face to face or telephonic contact for questionnaire administration.

Exclusion Criteria

• 1.Unstable medical/psychiatric condition requiring emergency treatment.
• 2.Communication difficulties .
• 3.Inability to read the questionnaire due to illiteracy.
• 4.Inability to read the questionnaire due to cognitive or physical impairment .
• 5.Patients presenting with acute symptoms requiring immediate medical attention.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Part I and II	Only at First visit
Cultural adaptation of English version	Only at First visit
Face validity	Only at First visit
Translation of the Brief COPE into Hindi	Only at First visit
Understandability, language, time to complete, etc of the questionnaire by 10% of the participants	Only at First visit
Part III	Only at First visit
Reliability of Brief COPE as measured by Cronbach’s alpha	Only at First visit
Discriminant validity for construct validity.	Only at First visit
Confirmatory Factor analysis	Only at First visit

Secondary Outcome Measures

Name	Time	Method
NA	NA

Trial Locations

Locations (1)

Tata Memorial Hospital; 🇮🇳 Mumbai, MAHARASHTRA, India

Tata Memorial Hospital

🇮🇳Mumbai, MAHARASHTRA, India

Jayita Deodhar

Principal investigator

9892358023

jukd2000@yahoo.co.uk